In fact, a recent pilot study in 100 patients found a strong trend towards reduction in mortality from COVID-19 in those patients with higher red blood cell EPA + DHA content.
← all excerpts
Lipidomics and metabolomics signatures of SARS-CoV-2 mediators/receptors in peripheral leukocytes, jejunum and colon.
1
—
—